DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts. 2011

E Karouzakis, and Y Rengel, and A Jüngel, and C Kolling, and R E Gay, and B A Michel, and P P Tak, and S Gay, and M Neidhart, and C Ospelt
Center of Experimental Rheumatology and Zurich Center of Integrative Human Physiology (ZIHP), University Hospital Zurich, Zurich, Switzerland. emmanuel.karouzakis@usz.ch

In the search for specific genes regulated by DNA methylation in rheumatoid arthritis (RA), we investigated the expression of CXCL12 in synovial fibroblasts (SFs) and the methylation status of its promoter and determined its contribution to the expression of matrix metalloproteinases (MMPs). DNA was isolated from SFs and methylation was analyzed by bisulfite sequencing and McrBC assay. CXCL12 protein was quantified by enzyme-linked immunosorbent assay before and after treatment with 5-azacytidine. RASFs were transfected with CXCR7-siRNA and stimulated with CXCL12. Expression of MMPs was analyzed by real-time PCR. Basal expression of CXCL12 was higher in RASFs than osteoarthritis (OA) SFs. 5-azacytidine demethylation increased the expression of CXCL12 and reduced the methylation of CpG nucleotides. A lower percentage of CpG methylation was found in the CXCL12 promoter of RASFs compared with OASFs. Overall, we observed a significant correlation in the mRNA expression and the CXCL12 promoter DNA methylation. Stimulation of RASFs with CXCL12 increased the expression of MMPs. CXCR7 but not CXCR4 was expressed and functional in SFs. We show here that RASFs produce more CXCL12 than OASFs due to promoter methylation changes and that stimulation with CXCL12 activates MMPs via CXCR7 in SFs. Thereby we describe an endogenously activated pathway in RASFs, which promotes joint destruction.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010003 Osteoarthritis A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans. Arthritis, Degenerative,Osteoarthrosis,Osteoarthrosis Deformans,Arthroses,Arthrosis,Arthritides, Degenerative,Degenerative Arthritides,Degenerative Arthritis,Osteoarthritides,Osteoarthroses
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D005260 Female Females
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

E Karouzakis, and Y Rengel, and A Jüngel, and C Kolling, and R E Gay, and B A Michel, and P P Tak, and S Gay, and M Neidhart, and C Ospelt
January 2016, RMD open,
E Karouzakis, and Y Rengel, and A Jüngel, and C Kolling, and R E Gay, and B A Michel, and P P Tak, and S Gay, and M Neidhart, and C Ospelt
December 2009, Arthritis and rheumatism,
E Karouzakis, and Y Rengel, and A Jüngel, and C Kolling, and R E Gay, and B A Michel, and P P Tak, and S Gay, and M Neidhart, and C Ospelt
October 2017, Inflammation,
E Karouzakis, and Y Rengel, and A Jüngel, and C Kolling, and R E Gay, and B A Michel, and P P Tak, and S Gay, and M Neidhart, and C Ospelt
October 2013, International journal of molecular medicine,
E Karouzakis, and Y Rengel, and A Jüngel, and C Kolling, and R E Gay, and B A Michel, and P P Tak, and S Gay, and M Neidhart, and C Ospelt
January 2010, Molecular medicine (Cambridge, Mass.),
E Karouzakis, and Y Rengel, and A Jüngel, and C Kolling, and R E Gay, and B A Michel, and P P Tak, and S Gay, and M Neidhart, and C Ospelt
July 2014, Journal of molecular medicine (Berlin, Germany),
E Karouzakis, and Y Rengel, and A Jüngel, and C Kolling, and R E Gay, and B A Michel, and P P Tak, and S Gay, and M Neidhart, and C Ospelt
November 2023, Biomedicines,
E Karouzakis, and Y Rengel, and A Jüngel, and C Kolling, and R E Gay, and B A Michel, and P P Tak, and S Gay, and M Neidhart, and C Ospelt
April 2008, Arthritis and rheumatism,
E Karouzakis, and Y Rengel, and A Jüngel, and C Kolling, and R E Gay, and B A Michel, and P P Tak, and S Gay, and M Neidhart, and C Ospelt
January 2000, The Journal of biological chemistry,
E Karouzakis, and Y Rengel, and A Jüngel, and C Kolling, and R E Gay, and B A Michel, and P P Tak, and S Gay, and M Neidhart, and C Ospelt
January 2015, Current pharmaceutical design,
Copied contents to your clipboard!